We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Alliance to Improve Radiation Therapy

By HospiMedica staff writers
Posted on 12 Oct 2004
Print article
Calypso Medical (Seattle, WA, USA) has announced a strategic collaboration with Philips Medical Systems (Best, The Netherlands) that will enable the development of products with the potential to deliver both adaptive and image-guided radiation therapy (IGRT). The collaboration was announced at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Atlanta (GA, USA) in October 2004.

Philips expects to provide enhancements to its treatment planning systems with target localization from the Calypso 4D Localization system as a result of this collaboration. The Localization system was designed to provide an objective and continuous method to setup treatment and monitor the patient during radiation delivery without adding ionizing radiation.

"Working together with the leaders in the field of radiation therapy, we can provide the ‘missing link' to advance radiation treatment options,” said Eric R. Meier, Calypso Medical's president and CEO. "Today's highly conformal radiation therapy treatment options rely on knowing the exact location of the target moment to moment. Establishing a relationship with Philips marks a commitment to advance planning and delivery techniques such as adaptive radiation therapy.”

Using its proprietary AC electromagnetic technology, the Calypso system has excellent capability to pinpoint the target continuously throughout the treatment process, without adding ionizing radiation. The open-system architecture design enables the integration of localization and tracking information through the care pathway from simulation through treatment delivery.

"Calypso Medical's technology, in conjunction with the Pinnacle3 and AcQSim treatment planning and simulation solutions from Philips, has the potential to deliver on the promise of adaptive and image-guided radiation therapy. The end result is expected to be among the most precise treatments available to patients,” remarked Keith Tipton, general manager, radiation oncology, Philips Medical Systems.


Related Links:
Calypso Medical
Philips Medical Systems
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Facet Fixation System
ZYFUSE
New
Hemodynamic Monitoring Sensor
FloTrac

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.